Verano Holdings (VRNO) Times Interest Earned (2021 - 2026)
Verano Holdings' (VRNO) quarterly Times Interest Earned came in at $0.09 in Q1 2026, down 61.4% year-on-year from $0.23 in Q1 2025, and down 98.19% on a QoQ basis from $4.83 in Q4 2025.
Verano Holdings (VRNO) Times Interest Earned (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Times Interest Earned data on file, last reported at $0.09 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 61.4% year-over-year to $0.09 in Q1 2026; TTM through Mar 2026 was -$0.73, a 80.32% increase from a year earlier, with the FY2025 full-year figure at -$0.37, up 91.81% from the prior year.
- Times Interest Earned for Q1 2026 stood at $0.09, down from $4.83 in the prior quarter.
- Over the last five years, Times Interest Earned for VRNO reached as high as $4.83 in Q4 2025 and fell as low as -$23.88 in Q4 2024.
- Historically, Times Interest Earned has averaged -$1.69 across 5 years, with a median of $0.18 in 2024.
- Across the five-year window, Times Interest Earned soared 1605.54% in 2023 and plunged 1681.75% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$12.66 in 2022, then soared by 89.42% to -$1.34 in 2023, then plunged by 1681.75% to -$23.88 in 2024, then soared by 120.23% to $4.83 in 2025, then slumped by 98.19% to $0.09 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were $0.09 in Q1 2026, $4.83 in Q4 2025, and $0.14 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 4.83 |
| Sep 30, 2025 | 0.14 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.23 |
| Dec 31, 2024 | -23.88 |
| Sep 30, 2024 | 0.18 |
| Jun 30, 2024 | 0.30 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | -1.34 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.34 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | -12.66 |
| Sep 30, 2022 | 1.74 |
| Jun 30, 2022 | -0.02 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 3.53 |
| Sep 30, 2021 | 2.67 |